News

Mr Singer is CEO of The BrainScope Company, a privately held neurotechnology company. Mr Singer has held executive level positions at Revolution, where he was instrumental in the

This initial study of 20 healthy postmenopausal female patients aged 40 to 70 years resulted in peak concentrations in the range of those obtained with the commercially available

The termination of the manufacturing and distribution agreement allows RxElite to supply anesthetic gas products to its customers from alternative sources. RxElite said that it will work closely

Uresta continence care is designed to stop bladder leakage and help women to manage their stress urinary incontinence (SUI) with a conservative alternative to traditional products and surgery.

Ocimum Biosolutions’s knowledge of computer systems validation requirements and processes as well as its understanding of pharmaceutical and biotechnology laboratories combined with Clarmon’s solution, QAvalid, is said to

Under the collaboration, fqubed will expand the scope of its Tempest high throughput experimentation platform to evaluate potential formulations for its partner’s product portfolio. Tempest is currently used

The combined solution is a fully integrated software package that consists of TomTec’s Image-Arena and Medis’s QAngio XA quantification software. It will be available as one platform that

The termination was based on the company’s determination that it no longer required the services of Dr Karlin. Dr Karlin’s responsibilities will be assumed by Robert Jager, chief

This agreement is said to be Virtual Radiologic’s first Enterprise Connect agreement outside the US, and will provide Pro-Laudo with increased efficiency and allow for rapid market penetration.